Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates
Authors' conclusion
The most common subtype in our cohort of patients is oligoarticular JIA. Longest delay is for ERA subtype. All our patients with oligoarticular JIA received Intra articular steroid injection as first line treatment. 49% of our patients received biologic treatment similar to rate in Northern Europe. Our remission rate is 67% with 11% of patients are in remission off treatment.
Study context
- Population
- Patients with JIA presenting to one centre in Abu Dhabi, UAE, for treatment and follow-up, 2011 to end of 2021
- Participants
- 138 patients
- Exposure
- Oligoarticular vs RF-negative polyarticular vs Enthesitis Related Arthritis (ERA) vs Psoriatic vs Systemic JIA vs Undifferentiated
- Oligoarticularn = 75
- RF-negative polyarticularn = 32
- ERAn = 10
- Outcome
- Subtype frequency, demographic features, treatments received and outcome
Methodological detailssingle-centre, retrospective case notes review
- Single-centre
- Retrospective case notes review
Main finding
As reported in the abstract
JIA subtype frequency
Observational data: associations, not effects.
Further findings
Diagnostic delay
Treatment received
- Steroid treatment
- 131 (96%)
- Did not receive steroids
- 6
- MTX
- 101 (73%)
- Biologic treatment
- 68 (49%)
Clinical remission · follow up ranging from 1 to 5 years
- Clinical remission
- 93 (67%)
- In remission on treatment
- 78 (56% of all; 84% of patients in remission)
- In remission off treatment
- 15 (11% of all; 16% of patients in remission)
Original publication
Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates. Pediatr Rheumatol Online J. Published 7 February 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →